Initial Treatment for Hyperthyroidism
Beta-blockers (atenolol 25-50 mg daily or propranolol) are the initial treatment for symptomatic hyperthyroidism to provide rapid symptom relief while definitive therapy is being planned. 1
Immediate Symptomatic Management
- Start beta-blocker therapy immediately for symptomatic patients presenting with tachycardia, palpitations, anxiety, tremor, or heat intolerance 1
- Titrate atenolol to achieve heart rate <90 bpm if blood pressure allows 1
- Beta-blockers work rapidly to control cardiac symptoms while thyroid hormone levels remain elevated 1
Definitive Treatment Selection (Based on Etiology)
For Thyroiditis (Self-Limited)
- Supportive care with beta-blockers only - do not start antithyroid drugs 1
- Monitor thyroid function every 2-3 weeks to detect transition to hypothyroidism 1
- Hyperthyroid phase typically resolves within weeks, most commonly progressing to hypothyroidism 1
For Graves Disease or Toxic Nodules (Autonomous Production)
Antithyroid drug therapy is the initial definitive treatment, with methimazole as first-line agent 1, 2, 3, 4:
- Methimazole 10-20 mg daily (single dose) is preferred over propylthiouracil 2, 5
- Starting dose should not exceed 15-20 mg/day to minimize risk of agranulocytosis 2
- Propylthiouracil is reserved only for:
Important Clinical Pitfalls
- Do NOT use high-dose corticosteroids routinely for hyperthyroidism - they are not indicated 1
- Distinguish thyroiditis from Graves disease early: TSH receptor antibodies and clinical features (ophthalmopathy, thyroid bruit) indicate Graves disease requiring different management 1
- Stop antithyroid drugs at least one week before radioiodine to reduce treatment failure risk 2
- Monitor for agranulocytosis (fever, sore throat) especially in first 3 months of thionamide therapy 6, 2
Severity-Based Approach
Grade 1-2 (Mild-Moderate Symptoms):
- Continue evaluation while starting beta-blocker 1
- Add antithyroid drug once etiology confirmed (if Graves/toxic nodules) 1
Grade 3-4 (Severe/Life-Threatening):